Partner Investment Management, L.P. 13F 持仓 · 最近申报 2019年Q4
Partner Investment Management 在 2019年Q4（报告期截至 2019-12-31）的 SEC 13F 申报中报告了 40 只证券，申报市值合计 1,392.80 万美元。前几大持仓：BOLD1（7.65%）、ALXN（6.54%）、ALNAQ（5.57%）。本季前 25 大持仓中：新建仓 7 只、增持 1 只、减持 16 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | BOLD1 | AUDENTES THERAPEUTICS INC | $1.1M | 7.65% | 17,795 | 减持 |
| 2 | ALXN | ALEXION PHARMACEUTICALS INC | $911,000 | 6.54% | 8,421 | 减持 |
| 3 | ALNAQ | ALLENA PHARMACEUTICALS INC | $776,000 | 5.57% | 284,285 | 持平 |
| 4 | GILD | GILEAD SCIENCES INC | $708,000 | 5.08% | 10,898 | 减持 |
| 5 | PEN | PENUMBRA INC | $608,000 | 4.37% | 3,699 | 减持 |
| 6 | ZBH | ZIMMER BIOMET HLDGS INC | $552,000 | 3.96% | 3,689 | 减持 |
| 7 | BIIB | BIOGEN INC | $546,000 | 3.92% | 1,839 | 新建仓 |
| 8 | NVRO | NEVRO CORP | $531,000 | 3.81% | 4,515 | 减持 |
| 9 | ELV | ANTHEM INC | $504,000 | 3.62% | 1,669 | 新建仓 |
| 10 | HUM | HUMANA INC | $494,000 | 3.55% | 1,347 | 新建仓 |
| 11 | CI | CIGNA CORP NEW | $453,000 | 3.25% | 2,216 | 减持 |
| 12 | IQV | IQVIA HLDGS INC | $452,000 | 3.25% | 2,926 | 减持 |
| 13 | BMRN | BIOMARIN PHARMACEUTICAL INC | $451,000 | 3.24% | 5,329 | 减持 |
| 14 | AERI | AERIE PHARMACEUTICALS INC | $436,000 | 3.13% | 18,035 | 增持 |
| 15 | AGN | ALLERGAN PLC | $436,000 | 3.13% | 2,282 | 减持 |
| 16 | ARNA | ARENA PHARMACEUTICALS INC | $431,000 | 3.09% | 9,484 | 减持 |
| 17 | CNC | CENTENE CORP DEL | $430,000 | 3.09% | 6,838 | 新建仓 |
| 18 | NVS | NOVARTIS A G | $392,000 | 2.81% | 4,270 | 减持 |
| 19 | HCA | HCA HEALTHCARE INC | $345,000 | 2.48% | 2,335 | 减持 |
| 20 | PFE | PFIZER INC | $294,000 | 2.11% | 7,492 | 新建仓 |
| 21 | ICUI | ICU MED INC | $258,000 | 1.85% | 1,381 | 新建仓 |
| 22 | DERM2 | DERMIRA INC | $256,000 | 1.84% | 16,892 | 减持 |
| 23 | ICLR | ICON PLC | $241,000 | 1.73% | 1,402 | 减持 |
| 24 | UNH | UNITEDHEALTH GROUP INC | $233,000 | 1.67% | 791 | 新建仓 |
| 25 | IRTC | IRHYTHM TECHNOLOGIES INC | $231,000 | 1.66% | 3,389 | 减持 |
来源：SEC 13F 申报文件 · 截至 2019-12-31
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR